CoC Source
April 30, 2013
Accreditation Corner
Clarification of Standard 1.1 and 1.9

The Standards Advisory Group for Excellence (SAGE) clarified the requirements for two standards.  These clarifications should assist programs to interpret the standards and understand how to comply with the requirements.

Standard 1.1: Physician Credentials

SAGE clarified that the standard applies to physicians in the following specialties:
Diagnostic radiology
Pathology
Radiation oncology
Medical oncology
General surgery
And, surgeons who care for patients that are in the facility’s five major sites of cancer. 

SAGE recognizes that there may be some variability in each facility’s 5th major site, however, this is primarily a stable group.  Programs will aggregate their top 5 sites over the 3 year accreditation period and supply board certification or CME information for this group of physicians.  Internal medicine and primary care physicians will not be included in this requirement.

Standard 1.9: Clinical Trial Accrual

Previously, SAGE had determined that CoC-accredited programs could count accrued patients only if the cancer-related clinical trial included a defined research question.  This excluded most bio repository and tissue banking trials and patients enrolled in a registry (similar to the PET registry).  SAGE has reconsidered this position and determined that patients with cancer from CoC-accredited programs who provide tissue and other specimens for bio repositories can be counted toward the clinical trial enrollment for this standard.

In addition, patients with cancer who are enrolled in registries for research purposes, e.g. PET registry, can also be counted toward this standard.

Please note that this clarification does not change the decision that patients accrued to the American Cancer Society CPS-3 study cannot be counted toward this standard.

Threads on both topics posted to the CAnswer Forum have been updated to reflect these decisions.  The SAR and the manual will be updated to reflect both changes as well.

If you have questions about either interpretation, please post your questions to the CAnswer Forum at http://cancerbulletin.facs.org/forums/.

Share: LinkedIn Twitter Facebook

< Previous Article | Return to Email | Next Article >
 
Forward to a Friend
Manage Your Subscription
Printer-Friendly Version
Mobile Version
Search Back Issues
Contact CoC Staff
 
In This Issue
 
79 Cancer Care Facilities Receive National Achievement Award
National Cancer Survivors Day
Visit us at the NCRA Annual Meeting May 30 - June 2 in San Francisco
Are You Receiving the Weekly CoC Brief?
CoC Recognizes Long-Standing Programs
Stakeholders Discuss Patient Quality of Life and Palliative Care at April Meeting
Clarification of Standard 1.1 and 1.9
Recent Publications and Forthcoming Presentations from the NCDB PUFs
Cancer Liaison Physician Activity Report
CLP NCDB Quality Reporting Tools Training at American Society of Clinical Oncology
Register Today for Survey Savvy and the Optional RQRS Workshop
NAPBC News
American Cancer Society News
NCRA News
Focus Under Forty Curriculum Offers Professional Education Opportunities
Surgical Investigators Meeting at the American Society of Breast Surgeons Annual Meeting
Joint International Oncology Congress
Monthly Spotlight: Oncology Nursing Society
 
Important Dates & Deadlines
   
   
Featured Resources
CoC Home Accreditation CLP Meetings Online Education NCDB Publications Coc Datalinks Forward to a friend Manage Subscription Print-Friendly Back Issues